Please login to the form below

Not currently logged in
Email:
Password:

antbody-drug conjugates

This page shows the latest antbody-drug conjugates news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA furthers antibody ambitions in cancer

Merck KGaA furthers antibody ambitions in cancer

Merck KGaA furthers antibody ambitions in cancer. Signs deal with Mersana to develop antibody-drug conjugates. ... Merck, via its biopharma division Merck Serono, will use Mersana's technology in polymer linking to create antibody-drug conjugates (ADCs).

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics